[Remote] Consultor Técnico Hematologia - São Paulo/SP at Eli Lilly and Company

Brazil

Eli Lilly and Company Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Formação na área da saúde e/ou administração, publicidade e propaganda e/ou áreas correlatas
  • Experiência prévia como consultor em hematologia será um diferencial
  • Visão analítica apurada, capaz de interpretar e comunicar dados complexos de forma clara
  • Proatividade e ousadia para propor soluções criativas e eficazes
  • Disponibilidade para viagens
  • Domínio pacote office
  • Residir em São Paulo/SP e cobrir toda a região do interior de São Paulo

Responsibilities

  • Fornecer consultoria técnica em hematologia, colaborando com insights e orientações valiosas
  • Desenvolver estratégias inovadoras para promover soluções personalizadas baseadas em evidências
  • Estabelecer e manter relacionamentos de confiança com stakeholders-chave no setor da saúde

Skills

Hematology
Healthcare Consulting
Analytical Skills
Stakeholder Management
Data Interpretation
Strategic Planning

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI